Papworth Hospital has announced its intention to appoint Skanska as the preferred bidder to lead the £206m project.
Although it remains subject to approvals from the Department of Health and HM Treasury, Skanska has been chosen to design, build and maintain the new Papworth Hospital when it relocates to the Cambridge Biomedical Campus.
Two consortia had been in the running for the scheme (first pictures of which have been released today):
- The Bouygues Consortium comprising Bouygues UK, Ecovert FM
- Skanska comprising Skanska Infrastructure Investment UK, Skanska Construction UK, Skanska Facilities Services, OCS.
Project director Ken Brewer said: “While the two bids were both very comprehensive the assessment of the bids followed a very robust process which resulted in the selection of the consortium led by Skanska.”
Chief Executive, Stephen Bridge, said the decision was “an important milestone in the ten-year project to move to our new site on the Cambridge Biomedical Campus”.
He said the Department of Health had cleared the business case to be forwarded to the Treasury for approval.
“The clinical, research and economic case for the new Papworth Hospital is beyond doubt and we look forward to relocating to the Cambridge Biomedical Campus which is fast becoming one of the most vibrant biomedical communities in the world.”
Construction of the 310-bed facility was originally due to begin in late 2012, with completion scheduled for late 2015. When this timetable slipped, the hospital trust originally expected approval in April 2013.
Papworth Hospital’s NHS Foundation Trust confirmed to Construction News in October that it does not expect to sign a contract with the preferred bidder until summer 2014, with the hospital not open to patients until early 2017.